tiprankstipranks
Advertisement
Advertisement

DE:8QQ Stock Latest News

Abcellera Warns Growing Generative AI Use Raises Cybersecurity, Privacy, and Operational Risks
Company AnnouncementsAbcellera Warns Growing Generative AI Use Raises Cybersecurity, Privacy, and Operational Risks
1M ago
ABCL
AbCellera (ABCL) Earnings Call: Liquidity, Risks, Catalysts
PremiumCompany Announcements
AbCellera (ABCL) Earnings Call: Liquidity, Risks, Catalysts
1M ago
ABCL
AbCellera reports FY25 EPS (49c) vs. (55c) last year
PremiumThe Fly
AbCellera reports FY25 EPS (49c) vs. (55c) last year
1M ago
ABCL
Is ABCL a Buy, Before Earnings?
PremiumPre-Earnings
Is ABCL a Buy, Before Earnings?
1M ago
ABCL
AbCellera doses first patients in Phase 2 portion of ABCL635 trial
PremiumThe Fly
AbCellera doses first patients in Phase 2 portion of ABCL635 trial
3M ago
ABCL
Viking Therapeutics names Neil Aubuchon as Chief Commercial Officer
PremiumThe FlyViking Therapeutics names Neil Aubuchon as Chief Commercial Officer
3M ago
ABCL
VKTX
AbCellera Secures Global Settlement and Patent License Deal
Premium
Company Announcements
AbCellera Secures Global Settlement and Patent License Deal
3M ago
8K
ABCL
AbCellera to receive $36M upfront in patent litigation settlement with Bruker
Premium
The Fly
AbCellera to receive $36M upfront in patent litigation settlement with Bruker
3M ago
ABCL
BRKR
Strategic Shift and Promising Antibody Therapeutics Drive Buy Rating for AbCellera Biologics
PremiumRatings
Strategic Shift and Promising Antibody Therapeutics Drive Buy Rating for AbCellera Biologics
4M ago
ABCL
AbCellera Appoints Dr. Stephen Quake to Board
PremiumCompany Announcements
AbCellera Appoints Dr. Stephen Quake to Board
5M ago
8K
ABCL
AbCellera Biologics’ Earnings Call: Key Insights
PremiumCompany Announcements
AbCellera Biologics’ Earnings Call: Key Insights
5M ago
ABCL
AbCellera downgraded to Market Perform from Outperform at Leerink
PremiumThe Fly
AbCellera downgraded to Market Perform from Outperform at Leerink
5M ago
ABCL
AbCellera Biologics Reports Q3 2025 Financial Results
PremiumCompany AnnouncementsAbCellera Biologics Reports Q3 2025 Financial Results
5M ago
ABCL
AbCellera Biologics Reports Q3 2025 Financial Results
Premium
Company Announcements
AbCellera Biologics Reports Q3 2025 Financial Results
5M ago
8K
ABCL
AbCellera reports Q3 EPS (19c), consensus (16c)
Premium
The Fly
AbCellera reports Q3 EPS (19c), consensus (16c)
5M ago
ABCL
AbCellera Biologics Appoints New Chief Medical Officer
PremiumCompany Announcements
AbCellera Biologics Appoints New Chief Medical Officer
7M ago
8K
ABCL
AbCellera appoints Sarah Noonberg as Chief Medical Officer
PremiumThe Fly
AbCellera appoints Sarah Noonberg as Chief Medical Officer
7M ago
MGX
ABCL
AbCellera doses first participants in Phase 1 trial of ABCL575
PremiumThe Fly
AbCellera doses first participants in Phase 1 trial of ABCL575
7M ago
ABCL
AbCellera Biologics Earnings Call: Clinical Progress and Financial Insights
PremiumCompany Announcements
AbCellera Biologics Earnings Call: Clinical Progress and Financial Insights
8M ago
ABCL
AbCellera price target raised to $7 from $5 at BMO Capital
PremiumThe FlyAbCellera price target raised to $7 from $5 at BMO Capital
8M ago
ABCL
AbCellera Biologics Advances Clinical Trials and Revenue Growth
Premium
Company Announcements
AbCellera Biologics Advances Clinical Trials and Revenue Growth
8M ago
ABCL
AbCellera Biologics: Promising Pipeline and Strategic Focus Justify Buy Rating
Premium
Ratings
AbCellera Biologics: Promising Pipeline and Strategic Focus Justify Buy Rating
8M ago
ABCL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >